News

September 2003 Issue

In the News: 09/03

Finally, A Cure For RA? Latest results from trials involving tumor necrosis factor (TNF) inhibitors infliximab (Remicade) and etanercept (Enbrel), when used in combination with methotrexate, have rheumotologists talking about the possibility of a cure for rheumatoid arthritis. In one trial, in which infliximab was used with methotrexate to treat patients with early RA, nearly a third of the subjects went into remission. Another trial, conducted with patients with more established RA and using etanercept in…

To continue reading this entire article you must be a paid subscriber.

Subscribe to Arthritis Advisor

Arthritis Advisor is the first magazine published by one one of the world's leading orthopaedic hospitals specifically for people with arthritis.

Already subscribe but haven't registered for all the benefits of the website? Click here.

Subscriber Log In

Forgot your password? Click Here.